These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 10962335
1. Cell proliferation and apoptosis with BCL-2 expression in renal cell carcinoma. Zhang X, Takenaka I. Urology; 2000 Sep 01; 56(3):510-5. PubMed ID: 10962335 [Abstract] [Full Text] [Related]
2. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma. Zhu Z, Xing S, Cheng P, Li G, Yang Y, Zeng F, Lu G. J Huazhong Univ Sci Technolog Med Sci; 2004 Sep 01; 24(4):354-7. PubMed ID: 15587397 [Abstract] [Full Text] [Related]
4. Evaluation of cell proliferation, apoptosis, and angiogenesis in transitional cell carcinoma of the renal pelvis and ureter. Zhang X, Kong C, Takenaka I. Urology; 2001 May 01; 57(5):981-5. PubMed ID: 11337312 [Abstract] [Full Text] [Related]
5. Impact of frequent Bcl-2 expression on better prognosis in renal cell carcinoma patients. Itoi T, Yamana K, Bilim V, Takahashi K, Tomita F. Br J Cancer; 2004 Jan 12; 90(1):200-5. PubMed ID: 14710230 [Abstract] [Full Text] [Related]
6. Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth. Shin Lee J, Seok Kim H, Bok Kim Y, Cheol Lee M, Soo Park C. J Surg Oncol; 2003 Nov 12; 84(3):166-72. PubMed ID: 14598361 [Abstract] [Full Text] [Related]
8. Apoptosis and cell proliferation in medullary carcinoma of the breast: a comparative study between medullary and non-medullary carcinoma using the TUNEL method and immunohistochemistry. Kajiwara M, Toyoshima S, Yao T, Tanaka M, Tsuneyoshi M. J Surg Oncol; 1999 Apr 12; 70(4):209-16. PubMed ID: 10219015 [Abstract] [Full Text] [Related]
9. Apoptosis and its correlation with proliferative activity in rectal cancer. Kim YH, Lee JH, Chun H, Nam SJ, Lee WY, Song SY, Kwon OJ, Hyun JG, Sung IK, Son HJ, Rhee PL, Kim JJ, Paik SW, Rhee JC, Choi KW. J Surg Oncol; 2002 Apr 12; 79(4):236-42. PubMed ID: 11920781 [Abstract] [Full Text] [Related]
10. Proliferation of renal cell carcinoma assessed by fixation-resistant polyclonal Ki-67 antibody labeling. Correlation with clinical outcome. Delahunt B, Bethwaite PB, Thornton A, Ribas JL. Cancer; 1995 Jun 01; 75(11):2714-9. PubMed ID: 7743475 [Abstract] [Full Text] [Related]
12. The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Xie X, Clausen OP, De Angelis P, Boysen M. Cancer; 1999 Sep 15; 86(6):913-20. PubMed ID: 10491515 [Abstract] [Full Text] [Related]
15. Basal cell adenocarcinoma of the salivary glands: comparison with basal cell adenoma through assessment of cell proliferation, apoptosis, and expression of p53 and bcl-2. Nagao T, Sugano I, Ishida Y, Hasegawa M, Matsuzaki O, Konno A, Kondo Y, Nagao K. Cancer; 1998 Feb 01; 82(3):439-47. PubMed ID: 9452259 [Abstract] [Full Text] [Related]
16. Apoptosis in prostatic adenocarcinomas; a study of relationship to Ki-67 and Bcl-2 protein expression. Tanji N, Yokoyama M, Sugamoto T, Takeuchi M, Terada N. Anticancer Res; 1998 Feb 01; 18(2A):1111-6. PubMed ID: 9615774 [Abstract] [Full Text] [Related]
17. Clinical significance of mdm2 and p53 expression in bladder cancer. A comparison with cell proliferation and apoptosis. Shiina H, Igawa M, Shigeno K, Yamasaki Y, Urakami S, Yoneda T, Wada Y, Honda S, Nagasaki M. Oncology; 1999 Apr 01; 56(3):239-47. PubMed ID: 10202280 [Abstract] [Full Text] [Related]
18. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma. Uchida T, Gao JP, Wang C, Jiang SX, Muramoto M, Satoh T, Minei S, Shimura S, Irie A, Kameya T, Baba S. Urology; 2002 Apr 01; 59(4):615-20. PubMed ID: 11927338 [Abstract] [Full Text] [Related]